L'ablazione transcatetere come terapia di prima linea della fibrillazione atriale: Analisi delle attuali evidenze

Translated title of the contribution: Transcatheter ablation as first-line therapy of atrial fibrillation: Analysis of current evidence

Pasquale Santangeli, Ada Francesca Giglio, Luigi Di Biase, Andrea Natale

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations

Abstract

In patients with symptomatic atrial fibrillation refractory to antiarrhythmic therapy, catheter ablation is effective in restoring and maintaining sinus rhythm, in reducing hospitalization and improving quality of life. On the other hand, the role of catheter ablation as first-line therapy for atrial fibrillation is still controversial and has been recently evaluated by two randomized controlled trials and two consecutive case series. These studies showed the superiority of catheter ablation over antiarrhythmic therapy for the rhythm control of atrial fibrillation, with similar rates of complications between the two groups. According to these results, catheter ablation could be considered as first-line therapy for patients with symptomatic paroxysmal atrial fibrillation without significant heart disease.

Translated title of the contributionTranscatheter ablation as first-line therapy of atrial fibrillation: Analysis of current evidence
Original languageItalian
Pages (from-to)12-18
Number of pages7
JournalGiornale Italiano di Cardiologia
Volume14
Issue number1
DOIs
StatePublished - Jan 1 2013
Externally publishedYes

Keywords

  • Atrial fibrillation
  • Catheter ablation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Transcatheter ablation as first-line therapy of atrial fibrillation: Analysis of current evidence'. Together they form a unique fingerprint.

Cite this